Danaher (DHR) PT Lowered to $220 at Stifel on Bioprocess Underperformance
Tweet Send to a Friend
Stifel analyst Daniel Arias lowered the price target on Danaher (NYSE: DHR) to $220.00 (from $260.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
